51
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found
      Is Open Access

      Incremental Cost of Conducting Population-Based Prevalence Surveys for a Neglected Tropical Disease: The Example of Trachoma in 8 National Programs

      PLoS Neglected Tropical Diseases
      Public Library of Science

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction Trachoma is an eye disease, caused by infection with ocular Chlamydia trachomatis, which causes blindness. However, trachoma can be treated and prevented through the SAFE strategy, endorsed by the World Health Organization (WHO): Surgery for trichiasis; Antibiotic therapy through mass distribution; Facial cleanliness promotion through health education; and Environmental improvement with sanitation. Trachoma is endemic in 57 countries worldwide, with the burden of disease concentrated in sub-Saharan Africa and the Middle East[1]. The WHO estimates that over 80 million people currently have active trachoma and another 8 million suffer from trichiasis, with a potential productivity loss of $2.9 billion annually at the global scale[2]. The World Health Assembly has set 2020 as the target date for the elimination of blinding trachoma worldwide[3]. Where trachoma is suspected to be a public health problem, the WHO recommends that the prevalence of the clinical signs of the disease are estimated using a cluster random survey methodology at the district level[4]. There are two other less common methods used to assess the burden of trachoma disease: trachoma rapid assessments (TRA); and acceptance sampling trachoma rapid assessment (ASTRA)[5], [6]. As demonstrated in the literature[7], the population-based probability sampling (PBPS) method is the most epidemiologically robust method available to generalize the prevalence of clinical signs to the domain of interest. In brief, the PBPS method employs a multi-stage cluster random survey design to randomly select clusters, and households within the clusters. Once households are selected, all members of the household are examined for clinical signs of trachoma disease using the WHO Simplified Grading System[8]. Survey team members are trained to conduct trachoma grading and household selection before participating in survey field work. Most survey teams consist of pairs of trachoma examiners and recorders, with one or two pairs needed to survey a cluster. Upon completion, double entry of survey data and analysis are performed by temporary staff or non-governmental organizations and Ministry of Health personnel. Trachoma prevalence surveys provide an estimate of the burden of disease at the level of interest, usually the district. These data serve as the evidence base for determining how the SAFE strategy should be employed. For example, where the prevalence of the clinical grade TF (trachomatous inflammation, follicular) exceeds 10% in children aged 1–9 years, the WHO recommends district-wide mass treatment with antibiotics and facial cleanliness and environmental improvements—the “AFE” of SAFE. Prevalence survey data are also used to calculate annual intervention targets and ultimate intervention goals (UIGs), such as the number of people who require trichiasis surgery. These targets are used to plan annual activity budgets, forecast the need for donated pharmaceuticals and other supplies, and monitor progress towards the elimination of blinding trachoma. Although survey implementation may vary by location, there are currently no data on the cost of trachoma prevalence surveys in the peer-reviewed literature. There are examples in the literature where different survey methods were compared to determine the most cost-effective method to estimate immunization coverage[9], [10]. While comparisons such as these can be used to evaluate the cost-effectiveness of different survey methods, they do not provide sufficient data to generalize the cost of conducting these surveys at the regional or global level. In this paper, we present an analysis of costs incurred in the implementation of trachoma prevalence surveys across eight national trachoma control programs. The findings from this analysis will enable national trachoma program managers and international partners to budget for trachoma prevalence mapping appropriately. Methods Ethics Statement The analysis of prevalence survey cost data did not involve any research on human subjects. The prevalence surveys reviewed in this paper were conducted in accordance with the Declaration of Helsinki and reviewed by the Emory University Institutional Review Board or the London School of Hygiene and Tropical Medicine (LSHTM) Ethical Committee and each country's respective Ministry of Health. External funding for the prevalence surveys was as follows: LSHTM, The Gambia survey; Helen Keller International, Sikasso Region of Mali; The International Trachoma Initiative and The Carter Center, 18 districts in Ghana; The Carter Center, all other surveys. Data Collection A systematic review of trachoma prevalence surveys conducted in Ethiopia, Ghana, The Gambia, Mali, Niger, Nigeria, Sudan, and Southern Sudan was performed February through May 2010. This review of prevalence survey costs included surveys that employed a PBPS methodology to estimate trachoma prevalence at the district level, or the administrative unit equivalent to a district (administrative unit with population of approximately 100–250 thousand people: woreda in Ethiopia, region in The Gambia, local government area in Nigeria, locality in Sudan, and county in Southern Sudan). Included surveys were implemented from 2006–2010, and funded or co-funded by The Carter Center, LSHTM (The Gambia), The International Trachoma Initiative (Ghana), or Helen Keller International (Sikasso Region, Mali). All surveys were ‘cluster random surveys’ that used a two stage sampling process to select clusters (communities, villages, or enumeration areas) representative of the domain in the first stage and households within the cluster in the second. The numbers of clusters and households in the surveys was not constant between districts. A data collection tool was used to collect the actual costs incurred in local currency during survey activities from accounting records in the programs. The tool collected data for four cost activities: training, field work, supervision and data entry. Training included costs such as per diem of trainees and trainers, meeting facility and supplies, transportation to the practical exercise and any required overnight accommodation. Field work costs included per diems for survey personnel (trachoma grader and recorder), transportation of survey field team, accommodation and supplies such as tetracycline eye ointment and magnifying loupes. Supervision included any per diem, transport and accommodation paid to Ministry of Health or NGO personnel retained for supervision of field work activities. Data entry costs included per diem of data entry clerks, cost of computer rental and information technology support (if required) and supplies. For each cost activity, data were collected on the number of people paid, the daily rate and the number of days paid. Transportation costs included any vehicle rental, fuel expense and driver per diem. The data collected in this study captured the incremental cost of conducting prevalence surveys in the context of an existing national trachoma control program. Ministry of Health and NGO salaries and other associated costs were not included in the analysis. Integrated prevalence surveys (more than one disease measured) were excluded from this analysis. “Headquarters” expenses were not included in the primary analysis of prevalence survey costs. Although beneficial, consultant or other outside technical assistance is not required for a national program to conduct trachoma prevalence surveys. Furthermore, the cost of outside technical assistance is dependent on travel expense policies which are unique to each partner. The cost of Carter Center headquarter support for specific survey activities are reported in this review, but were not included in the district-level cost data, as these costs are organization-specific and cannot be generalized. Once completed, the cost data forms were verified against the financial reports from the Carter Center, Helen Keller International, LSHTM or the Ministries of Health. In Ghana, Ethiopia and Northern Sudan, exact data on distance traveled were not available; the data reported for these programs' distance traveled are estimates from the national programs. Data Analysis Data were converted to US dollars using the mean of the weighted average exchange rate from the World Bank (http://data/worldbank.org/indicator/PA.NUS.FCRF) for the years 2007–2009. Since most district-level prevalence surveys were conducted in groups (i.e. all districts in a region surveyed at the same time), costs were not reported for each individual district. Rather, each “grouping” of surveys that were financed at the same time was analyzed as the same observation. For example, in the Kayes Region of Mali, all 7 districts were surveyed using the same survey personnel within the same period of time. Funds were provided to the Ministry of Health to conduct the survey work for the entire region, which resulted in efficiencies gained by conducting one initial training and reducing the amount of transport required. Where data were reported in this fashion, the districts are treated as the same observation in the analysis. Based on these observations, the analysis generates the overall costs, the average survey costs per district and average costs per cluster for each observation. Data were first entered into Excel and then analyzed using STATA to generate descriptive statistics for each cost activity. Subsequently, a cost composition analysis was performed. The data were classified into activities as defined in the data collection tool to calculate the proportion of the total cost for each cost activity. Within each of the four activities (training, field work, supervision and data entry), four main cost categories were identified: personnel, transportation, supplies and other. The costs for each category were compared against the total cost for each activity to identify the main cost drivers of survey expenses. Normally distributed data are presented as the mean and standard deviation (SD). Not-normally distributed data is presented by the median and inter-quartile range (IQR). Results Survey Costs A total of 29 observations were collected from eight national trachoma control programs. The cost per district by observation is presented in Table 1. Overall, a total of 165 district-level surveys were included (Figure 1), representing a total of 3,203 clusters surveyed. The average costs per district were skewed to the right by an outlier (Ayod in Southern Sudan, $25,409) so are described by the median, $4,784 and IQR, $3,508–$6,650. The median cost per cluster was $311 (IQR = $119–$393) whilst the median cost per person screened was $3.50 (IQR = 1.94–4.16). (The mean cost per district, cluster and person was $5,849 (SD = $4,635), $324 (SD = $236), and $3.39 (SD = $2.02) respectively). The least expensive survey per district was in Ethiopia, approximately $1,511 per district. The number of districts, clusters and persons sampled per observation is presented in Table 1. 10.1371/journal.pntd.0000979.g001 Figure 1 Map of district-level trachoma prevalence surveys included in the cost analysis. 10.1371/journal.pntd.0000979.t001 Table 1 Summary of total costs, by observation. National program Observation Number of districts Number of clusters Number of households per cluster Number of people examined Total costs ($) Cost per district ($) Cost per cluster ($) Cost per person screened ($) Reference Ghana Northern & Upper West 18 720 30 74,225 72,249 4,014 100 0.97 Yayemain 2009 Mali Kidal 1 20 24 2,165 14,777 14,777 739 6.83 Bamani 2010 Kayes 7 140 24 13,576 13,593 1,942 97 1.00 Bamani 2010 Koulikoro 9 180 24 19,342 17,505 1,945 97 0.91 Bamani 2010 Sikasso 8 160 24 18,795 19,046 2,381 119 1.01 PNLCC Segou 8 160 24 16,471 18,553 2,319 116 1.13 PNLCC Nigeria Plateau & Nasarawa 13 260 16 21,606 24,036 1,849 92 1.11 King 2010 Southern Sudan Jonglei (Ayod County) 1 20 20 2,335 25,409 25,409 1,270 10.88 King 2008 Northern Sudan Kassala 10 132 30 10,576 35,308 3,531 267 3.34 FMOH GOS Blue Nile 4 45 20 5,166 18,799 4,700 418 3.64 FMOH GOS Gazeira 7 105 20 10,466 42,049 6,007 400 4.02 FMOH GOS White Nile 8 120 20 10,570 39,168 4,896 326 3.71 FMOH GOS Gadarif 10 150 20 13,682 47,839 4,784 319 3.50 FMOH GOS Sinnar 7 105 20 9,095 34,961 4,994 333 3.84 FMOH GOS River Nile 6 90 20 7,528 20,632 3,439 229 2.74 FMOH GOS Red Sea 10 150 20 9,918 40,680 4,068 271 4.10 FMOH GOS Northern 5 66 20 11,076 36,454 7,291 552 3.29 FMOH GOS North Kordofan 9 135 20 10,360 37,494 4,166 278 3.62 FMOH GOS South Kordofan 9 135 20 10,755 41,960 4,662 311 3.90 FMOH GOS Niger Magaria 1 20 24 1,789 7,884 7,884 394 4.41 PNLCC Niger Matameye 1 20 24 1,712 7,835 7,835 392 4.58 PNLCC Niger Nguigmi 1 20 24 1,659 7,866 7,866 393 4.74 PNLCC Niger Maine Soroa 1 20 24 1,867 7,866 7,866 393 4.21 PNLCC Niger Maradi Commune 1 20 24 2,393 6,132 6,132 307 2.56 PNLCC Niger Tessaoua 1 20 24 1,806 6,132 6,132 307 3.40 PNLCC Niger Gaya 1 20 24 2,036 6,650 6,650 333 3.27 PNLCC Niger Loga 1 20 24 1,801 6,650 6,650 333 3.69 PNLCC Niger Ethiopia Amhara 5 90 10 5,762 7,556 1,511 84 1.31 Ngondi 2008 The Gambia Lower River & North Bank 2 60 25 2,990 7,815 3,908 130 2.61 Harding-Esch 2009 Total 165 3,203 301,552 672,897 Composition of Survey Costs When the costs for each survey activity were compared against the total cost (Table 2), the data showed that field work comprised on average 69.9% of the total cost of a survey. Among the observations, the proportion of total costs spent on field work ranged from 44.9% to 90.5%. Training costs ranged from 1.0% to 29.6% of total costs, supervision expenses were between 0.0% and 20.9% of the total, and data entry costs ranged from 0.0% to 25.0% across all observations. Within each survey activity, personnel costs were the most expensive, with personnel costs in field work accounting for 40.4% of the total survey costs reported by the national programs, followed by transportation during field work at 22.4%. 10.1371/journal.pntd.0000979.t002 Table 2 Average proportion of total survey costs attributed to cost categories and activities. Activities Training Field work Supervision Data entry Total Category Personnel 1.9% 40.4% 11.3% 10.9% 64.6% Transportation 1.6% 22.4% 1.7% 0.0% 25.7% Supplies 0.9% 5.3% 0.0% 0.0% 6.3% Others 1.4% 1.7% 0.3% 0.0% 3.3% Total 5.9% 69.9% 13.2% 10.9% 100.0% Training and data entry activity costs were reported by observation as the cost for each activity. These costs were not always directly related to the number of districts surveyed as some programs did not incur cash costs for these activities. The mean cost of training was $1,342 (SD $659) while the median was $1,791.50 (IQR = $588–$1,816). The mean cost of data entry was $2,548 (SD $3,493) and the median was $1,028 (IQR = $415–$4,431). Costs of ‘Headquarters’ Participation in Surveys Although the cost of outside technical assistance was not factored into the district or cluster level cost analysis, there were 9 observations that were surveyed with at least one representative from The Carter Center Headquarters (Atlanta, Georgia, USA) present, covering a total of 58 districts. The average cost for airfare, hotel, meals and incidentals per person-trip was $1,779 (n = 13, SD = $2,027) from 2006–2010. Discussion It is possible that trachoma control programs do not implement prevalence surveys due to a perception that the costs will be beyond the capacity of the program. However, the results of this analysis show that such surveys are not cost-prohibitive. The range of costs per district varied from $1,151–$25,409, in large part due to differences in accessibility and the number of clusters sampled in each survey. Of the 29 observations, only three surveys reported a cost per cluster exceeding $500: Ayod in Southern Sudan, Kidal in Mali and the Northern Region in Sudan. These surveys were characterized by both high transport and personnel costs. In Ayod County of Southern Sudan, where the average cost per cluster was $1,270 and average cost per person screened was $10.88, vast distances of water-logged and unforgiving terrain made vehicle transport impossible, requiring a chartered airplane to transport staff to airstrips from where they traveled to the clusters on foot over a period of days. These exceptional circumstances therefore required additional staff, working for a longer period of time, and transport by chartered aircraft. In Kidal Region (a desert region of Mali), the second most expensive survey per cluster ($739 per cluster, $6.83 per person screened), the sparse population (80,000) and low population density (less than one person per square kilometer) resulted in the national program treating the region as the domain, with the consequence that the distances between clusters was hundreds of kilometers. To conduct this survey, the program rented vehicles instead of using Ministry of Health and NGO transport due to security concerns in the area. The Northern Region of Sudan ($552 per cluster, $3.29 per person screened) is also on the edge of the Sahara with similar demands on transport and time. Least expensive, at under $100 per cluster, were the surveys conducted in the Amhara region of Ethiopia ($84 per cluster, $1.31 per person screened) and Plateau and Nasarawa States of Nigeria ($92 per cluster, $1.11 per person screened) where per diem rates were low and the population is relatively dense, reducing both the travel costs and time spent travelling between clusters. In total, 7 observations cost less than $125 per cluster and these also had the lowest cost per person screened ($0.91–$1.31). In these surveys, the relative proximity of clusters and low per diem rates contributed to lower costs in comparison to the more expensive surveys. Among the cost categories reported, the per diem of field staff and supervisors and the cost of transportation accounted for 73% of the total survey costs. In settings where distances between communities are great, trachoma control programs may consider reducing the number of clusters surveyed and increase the number of people screened per cluster to reduce costs but maintain an adequate sample size. However, the risks to accuracy and precision around the prevalence estimate should be considered. Cost savings on transport and accommodation costs can be achieved by planning the route of vehicles between clusters carefully. A route for two teams can often be planned in which the teams share one vehicle, work in the first and second clusters simultaneously (with the vehicle shuttling between as necessary) and then travel together to the next cluster where they camp for the night and sensitize the village population of the survey to be conducted the following day. Such transport sharing and camping has been both effective and enjoyable in most of the countries in this analysis. Per diem and allowance costs vary by national program, level of trained personnel recruited to serve as survey team members and local supervision requirements. Per diem costs in the surveys studied ranged from $6.21 per day for graders (junior health staff) to $250 a day for senior supervisors (an ophthalmology professor and National Coordinator). When designing surveys, due consideration should be given to assign roles and responsibilities consistent with the qualification and per diem given. Junior health staff who are comfortable with the climate, social circumstances and geography of the area to be surveyed make ideal field staff, and serve to lower per diem costs. It is appropriate for a National Coordinator or ophthalmology professor to spend a day or two testing the ability of the trained examiners before the survey starts, but costs can be reduced if that person does not spend many days in the field. The review of data entry costs also presents new findings for Ministries of Health. Although data entry was not an expense for all surveys reported, data entry accounted for an average of 11% of total survey expenses. In this sample, the incremental cost of data entry ranges from 0% in surveys where existing program staff conducted data entry on existing computers incurring no additional cash cost to 25% of the total cost of the survey where external contractors were hired to complete the work. Survey planners should consider the cost of data entry in their own country context to ensure that costs for double entry, analysis and preparation of printed reports are included in budgets. By design, we did not capture the cost of each Ministry of Health and NGO employee who contributed time to conduct survey work, the incremental cost effectiveness ratio is likely to be underestimated since these costs were not taken into account. This could be included in the analysis as an opportunity cost. However, since the implementation of prevalence surveys is recommended as the standard monitoring and evaluation framework for trachoma control programs by the WHO, these surveys were within the mandate of the Ministry of Health personnel who were engaged in field work and supervision. Salary costs were excluded as they were considered part of the functional trachoma control program and we sought to establish the incremental cost of conducting surveys in the presence of a program. We also did not include the cost of technical assistance (including travel) for ‘headquarters’ staff. Although the average cost of a person-trip from The Carter Center for technical assistance was $1,779 (SD = $2,027), we considered this to be a non-essential cost for a program, subject to considerable variation between supporting NGOs who have different travel policies, and likely to come from a different operating budget which would not have an incremental effect on the cost of a national program. The selection of a sample representative of the underlying population presents an opportunity to collect data on multiple conditions and this has been done for trachoma and malaria[11] and trachoma and urinary schistosomiasis[12]. Such integrated surveys were not included in this analysis since they were considered special cases and not what is typically done. However, the costs of adding indicators for additional diseases or conditions are the additional personnel, equipment and consumables required for that survey, with the other cost items such as transport and per diem of the drivers and assistants covered by the ‘parent’ survey. Although the data presented show costs from a variety of settings, there are a few limitations. The data in this analysis were reported retrospectively and therefore, it is possible that some costs may not have been captured. For some surveys (Ghana, Ethiopia and Northern Sudan) log book entries for distance travelled were not available and we relied on the local knowledge of the national program to calculate distance travelled. Each of these surveys was conducted in the presence of a functioning trachoma control program; there was no need to purchase new vehicles or make other large capital expenses. Survey work performed in the absence of this infrastructure would be more expensive. New country programs may find it necessary to rent vehicles and seek technical assistance for training survey staff, the costs of which would need to be considered in addition to the incremental costs of conducting a survey presented here. There are variations in the number of clusters surveyed among the different observations, based on the population of each survey domain, which may affect the comparability of the survey costs among different countries. However, the authors expected variation among national programs due to differences such as per diem rates, the level of qualified health professional involved in field work, and the capacity to complete data entry. The variation seen in these data illustrate the context-specific nature of planning survey activities. However, these limitations should not discourage program managers from using the data presented in this paper as benchmarks for determining funding needs. Twenty-six out of the 29 observations were conducted with external funding exclusively from The Carter Center, which may imply the cost estimates are limited to those surveys supported by this NGO. However, there are similarities between the cost per cluster from The Gambia, which was fully funded by LSHTM, districts in Mali supported by Helen Keller International, and districts in Ghana co-sponsored by the International Trachoma Initiative and The Carter Center. This suggests that our findings are not unique to the operating principles of one NGO. Since transport and per diem were identified as major cost drivers, it is possible to predict total survey costs for areas requiring surveys. It is also possible to use these data to project the cost of other survey methodologies by applying the average cost per cluster to the number of clusters required. Despite the potential limitations of this study, these data present the only summary of actual costs incurred during trachoma prevalence surveys in the peer-reviewed literature. For the goal of elimination of blinding trachoma worldwide by 2020 to be met, national programs will need to budget for impact evaluation at the district level. The cost of epidemiologically rigorous surveys should not been seen as a barrier to their implementation. With adequate baseline and impact evaluation data, national programs can maximize their limited programmatic resources. These data should inspire national trachoma program managers and ministry of health staff involved in other public health supervisory roles to consider implementation approaches that ensure surveys are designed in a cost-effective and efficient manner. These cost data will enable the international trachoma control community to create global estimates on the cost to complete trachoma prevalence mapping and estimate the financial needs to support impact assessments to measure progress towards the elimination of blinding trachoma.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: not found

          A simple system for the assessment of trachoma and its complications.

          A simple grading system for trachoma, based on the presence or absence of five selected "key" signs, has been developed. The method was tested in the field and showed good observer agreement, the most critical point being the identification of severe cases of the disease. It is expected that the system will facilitate the assessment of trachoma and its complications by non-specialist health personnel working at the community level.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Trachoma: global magnitude of a preventable cause of blindness.

            Trachoma is the leading cause of infectious blindness worldwide. It is known to be highly correlated with poverty, limited access to healthcare services and water. In 2003, the WHO estimated that 84 million people were suffering from active trachoma, and 7.6 million were severely visually impaired or blind as a result of trachoma: this study provides an updated estimate of the global prevalence of trachoma based on the most recent information available. A literature search of recent published and unpublished surveys in the 57 endemic countries was carried out: the result of surveys that used the WHO trachoma grading system and additional information from regional and country experts served as a basis to determine the prevalence of trachoma in each country. Population-based surveys provided recent information for 42 out of 57 endemic countries. 40.6 million people are estimated to be suffering from active trachoma, and 8.2 million are estimated to have trichiasis. The current estimate of prevalence of trachoma is lower than the previous WHO estimates: this can be explained by the success in implementing control strategy, by more accurate data, as well as by socio-economic development in endemic countries.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Integrating an NTD with One of “The Big Three”: Combined Malaria and Trachoma Survey in Amhara Region of Ethiopia

              Introduction Ethiopia is a rapidly developing country that is burdened and held back by a high prevalence of communicable disease. Of the so-called ‘big three’ killer diseases, HIV/AIDs, tuberculosis, and malaria, malaria is the most frequent cause of out-patient presentation and in-patient admission nationwide and is second only to respiratory tract infections as a cause of death in children [1]. Co-endemic with the ‘big three’ in Ethiopia are the ‘neglected tropical diseases’ of which trachoma is the most geographically widespread and cause of greatest morbidity. The Ethiopian national blindness and low vision survey conducted in 2006 suggests that Ethiopia is the most trachoma affected country in the world. The entire rural population of approximately 65 million people are at risk of blindness from trachoma. At any time there are an estimated 9 million children with clinical signs of active disease, 1.2 million adults with trachomatous trichiasis, and 354,000 persons with blindness or low vision attributed to trachoma [2]. In addition to the effects on vision and the high likelihood of developing blindness if unoperated [3], trichiasis is a terrible condition in which the eyelashes rub against the surface of the eye ball, leaving sufferers in constant and disabling pain. The irritation and pain caused by the lashes on the surface of the eye ball and cornea is exacerbated by smoke, dust and bright light which prevents people from conducting their normal routine activities such as cooking over solid fuel fires, farming in dusty environments, gathering firewood and collecting water [4]. Of the ten states in Ethiopia, Amhara Regional State is disproportionately affected by trachoma, bearing an estimated minimum of 45% of the national trichiasis burden and with approximately one in twenty of all adults suffering from trichiasis [2]. It is recognized that the geographic distribution of trachoma within the state is not uniform with some health posts reporting trachoma as the primary cause of out-patient consultations and for others, trachoma ranks below malaria and respiratory tract infection as a cause of out-patient consultation. Trachoma is a barrier to development in Amhara and controlling this disease is a state priority. Trachoma control in Amhara, and the whole of Ethiopia, is based on the World Health Organization (WHO) endorsed SAFE strategy, in which S is corrective lid surgery for patients with trichiasis, A is antibiotic treatment for individuals with signs of active disease and for mass drug administration to at-risk populations, F is facial cleanliness and hygiene promotion to prevent transmission, and E is environmental improvements such as provision of sanitation and water that address trachoma risk factors [5]. Nationally, it has been recognized that malaria is a major barrier to the development. Ethiopia including Amhara , is prone to unstable and epidemic malaria [6],[7],[8]. The Federal Ministry of Health has launched a control program of unprecedented scale and scope to relieve this burden. The program is based on personal protection/vector control, and effective case detection and treatment. It is being targeted to the entire Ethiopian population at risk of malaria (estimated at 50 million people) [9]. The program has four pillars: distribution of free long-lasting insecticidal nets (LLINs) at the target rate of two per household in malaria-endemic areas; targeted indoor residual spraying (IRS) in high transmission areas; serum-based rapid diagnostic tests (RDTs) available at all health facilities; and treatment with artemesinin combination therapy for Plasmodium falciparum malaria and chloroquine for uncomplicated malaria caused by Plasmodium vivax. In Amhara, the malaria is seasonal and follows the rain; presentation of malaria cases is most common from September to January, with a peak in November and December. The survey was conducted in December at the end of the normal peak transmission period. Recently, there have been a series of publications proposing that large single disease programs be integrated to improve efficiency and reduce costs [10], that programs specifically targeting the neglected tropical diseases be integrated and expanded [11], that neglected tropical disease programs be integrated with the ‘big three’ [12], and that deworming programs be integrated with malaria control [13]. It was in this climate that the Amhara Regional Health Bureau partnered with The Carter Center to plan an integrated malaria and trachoma control program that would simultaneously target two of the most devastating communicable diseases in the state: malaria and trachoma. Amhara (population approximately 19.6 million [14]) is divided administratively into 10 zones, which are themselves divided into 140 woredas (district equivalents), and 3,231 kebeles (groups of villages with approximately 5,000 population) (Figure 1, Map). Within kebeles the lowest administrative unit is the state team (now known as development teams) which are groups of about 50 families, usually around 250 people, who have an elected representative. Although national direction comes from the Federal Ministry of Health, overall coordination of programs has been devolved to the states, and planning for implementation is conducted by the woreda representatives at the level of the zone. In order to facilitate planning of the interventions and to enable evaluation at both state and zonal level, we conducted an integrated malaria and trachoma survey that was powered to provide prevalence estimates at the zonal level. The integrated survey had the following objectives. 10.1371/journal.pntd.0000197.g001 Figure 1 Map of Amhara Region of Ethiopia showing the survey sites. Malaria: 1) Estimate malaria parasite prevalence by species of parasite and age and gender of host at the zonal level; and 2) Estimate the coverage of indoor residual spraying, use of mosquito nets and use of long-lasting insecticidal nets. Trachoma: 3) Estimate the prevalence of trachomatous inflammation follicular (WHO grade TF) in children aged 1–9 years at the zonal level; 4) Estimate prevalence of trachomatous trichiasis (WHO grade TT) in adults aged over 15 years by zone and sex; and 5) Estimate other household risk factors for trachoma including latrine ownership, access to water supply, and facial cleanliness of children aged 1–9 years. The data from the integrated survey would allow calculation of programmatic needs for both components of the integrated program: malaria and trachoma. For malaria the number of long lasting insecticidal nets required to meet the distribution targets and information on current net usage for targeting health education messages; for trachoma the estimated backlog of TT surgeries, the population requiring mass drug administration with antibiotic and health education, and the need for household latrines and access to water. Methods Sample size calculation The sample size was calculated based on the assumption that prevalence of TT would be the lowest of the indicators that we wished to measure and we would determine prevalence estimates at the zonal level. For each zone we assumed a prevalence of TT in adults of 5%, 2.0% precision, 95% confidence limit, and a design effect of 2. We estimated that we needed to examine at lest 1,000 adults per zone. We assumed adults were 50% of the population, so that the total population sampled would need to be 2,000, and that household size was, on average, 5. This gives an estimated sample of 400 households per zone. Bahir Dar town was excluded from the sampling frame as were two special woredas ‘Debre Markos Ketema’ in East Gojjam and ‘Debre Tabor’ in South Gondar zone. The latter two were excluded because, in accordance with the Regional Health Bureau definition, less than 10% of their population lived in malarious areas; however, these two woredas comprised only 0.4% of the overall population. To select the 400 households in each zone we used a multi-stage cluster random sampling design. In each zone, eight woredas were selected using probability proportional to size and, within the selected woredas, we selected two kebeles also using probability proportional to size. Within the kebele, five state teams (which are all approximately similar in size) were selected by lottery, literally drawing the names out of a hat at the woreda office. In the final stage, five households were selected from the 50 in the state team using the random walk method. To determine malaria parasite prevalence, we assumed a population prevalence of 8%, 2% precision, 5% level of significance and 95% confidence limit, a design effect of 1.2 and 15% non-response to give an estimated sample size of 1,000 people or 200 households in each zone. Consequently, we arbitrarily determined that even-numbered households in the overall sample would be recruited for malaria blood films. In summary, the integrated survey had ten domains (the zones). Within each zone there were 16 clusters, each of 25 households to give a sample of 400 households or 2,000 people per zone. Overall there were 160 clusters of 25 households. Each zone had a different population, so that persons sampled within a zone represented a different proportion of the total population. State-wide prevalence estimates could be calculated from the weighted domain estimates. The survey was conducted in December 2006 at the end of the malaria transmission season. Household questionnaire The survey questionnaire was based on the Malaria Indicator Survey Household Questionnaire , modified for the local conditions and to include risk factors for trachoma [15]. The questionnaire was translated and printed in Amharic language and field-tested in a non-survey kebele to determine the validity of the pre-coded answers. Interviews were conducted with the head of household, or another adult if the head of household was absent or unable to respond for any reason. If interviews were conducted with someone other than the head of household then the respondent was requested to answer as though he or she were the head of household. The data collection form had three parts: household questionnaire; malaria parasite prevalence; and trachoma survey. In the household questionnaire respondents were asked about: their source of drinking water; time to collect water; toilet facilities (latrine presence, if reported, was verified by observation); proxy indicators of wealth; room construction materials; indoor residual spraying; presence and type of mosquito net (verified by observation); demographic information on residents; and where people slept. We defined the source of drinking water as being ‘safe’ if it was a capped spring, protected hand-dug well, tube well, borehole, cart with small tank, or piped water. Other water sources were described as ‘unsafe’ and were unprotected springs, unprotected hand-dug wells, and surface water. Our proxy indicators of wealth were electrification of the household, possession of a functioning radio set, and possession of a functioning television set. Malaria parasite prevalence Consenting residents of even-numbered households were recruited for the malaria parasite prevalence survey. Participants had both a rapid diagnostic test which gave an on-the-spot diagnosis and provided thick and thin blood films for microscopy. The rapid diagnostic test used was ParaScreen (Zephyr Biomedical Systems, www.tulipgroup.com), this test is able to detect both P. falciparum and other plasmodia species (in Amhara most likely P. vivax). The test uses approximately 100 µl of blood and is readable after ten minutes. Participants with positive rapid tests were offered treatment according to national guidelines, CoArtem® for P. falciparum infection, chloroquine for other Plasmodium infection, and clinic-based quinine therapy for self-reported pregnant women [16]. Two blood slides, each composed of thick and thin films, were taken for each participant by a clinical technician according to standard WHO-approved protocol [17]. Slides were labelled and air-dried horizontally in a carrying case in the field, and stained with Giemsa at the nearest health facility when the team returned from the field. Usually, field teams returned to the clinic each evening but when working in inaccessible areas, which required walking up to eight hours each way, they were obliged to sleep in the field and stain the slides the following day. To ensure maximum participation, households with absentees were revisited a second time on the same day to recruit those missing at the first visit. Blood slides were read at a reference laboratory in Addis Ababa and classified qualitatively as either negative, P. falciparum positive, P.vivax positive, or mixed infection. One hundred high power fields of the thick film were examined before calling a slide negative. If positive, the thin film was read to determine the species. Parasite density was not quantified. To ensure accuracy, all positive slides and a random sample of 5% of the negative slides were re-examined by a separate microscopist, who was blinded to the diagnosis of the first slide-reader. The second slide from each participant was used if the first was broken or unreadable. The identity of survey participants who had positive blood slides was sent back to the field teams for follow-up and appropriate treatment, where necessary. Trachoma survey Trachoma grading was carried out by Integrated Eye Care Workers (IECW) who were experienced in using the WHO simplified grading [18]. This scheme comprises of 5 stages: trachomatous inflammation-follicular (TF), trachomatous inflammation-intense (TI), trachomatous scarring (TS), trachomatous trichiasis (TT) and corneal opacity (CO) (Box 1). Minimum accepted inter-observer agreement was set at 80% and reliability assessed in two stages. In the first stage, potential examiners identified trachoma grades using the WHO set of trachoma slides [19]. Those examiners who achieved at least 80% agreement then proceeded to the second stage of field evaluation. During field evaluation a reliability study comprising 50 persons of varying age and sex were selected by the senior examiner to represent all trachoma grades. Each potential examiner evaluated all 50 subjects independently and recorded their findings on a pre-printed form. Inter-observer agreement was then calculated for each trainee using the senior examiner's observation as the ‘gold standard’. Examiners achieving at least 80% inter-observer agreement after the field evaluation were included as graders. All persons living within each selected household who gave verbal consent were examined using a torch and a x2.5 magnifying binocular loupe. Each eye was examined first for in-turned lashes (TT), and the cornea was then inspected for corneal opacities (CO). The upper conjunctiva was subsequently everted and examined for inflammation (TF and TI) and scarring (TS). Both eyes were examined. Signs had to be clearly visible in accordance with the simplified grading system in order to be considered present. Alcohol-soaked cotton-swabs were used to clean the examiner's fingers between examinations. Individuals with signs of active trachoma (TF and/or TI) were offered treatment with 1% tetracycline eye ointment. TT patients were referred to health centres where free eyelid surgery was available. Data to determine whether children aged 1–9 years had a ‘clean face’ were collected during the eye examinations. Facing the child, the observer looked for the presence of ocular and nasal discharge, recording each separately as a dichotomous variable. Ocular discharge was defined as any material of any colour or consistency in the corner of the eyes, or matting of the eyelashes caused by such a discharge (tears, medication and make-up were excluded). Nasal discharge was defined as the presence of wet exudate of any colour below one or both nostrils. Quality control, data entry and analysis Forms were checked by the supervisor in the field and inconsistencies verified with the respondent. Data were double entered by different entry clerks and compared for consistency using Census and Survey Processing System (U.S. Census Bureau Washington DC, USA). Statistical analysis was conducted using Stata™ 9.2 (Stata Corporation, College Station, Texas, USA). Descriptive statistics were used to describe the characteristics of the sample. Sampling probabilities were calculated for woredas, kebeles and state teams. Sampling weights were then derived as the inverse of the product of sampling probabilities at the woreda, kebele and state team levels. Point estimates and confidence intervals were derived using the SURVEY (SVY) routine in Stata which controls for clustering and allowed for adjustments for the sampling design as well as weighting for sampling probability [20]. To give greater precision in the estimates of trichiasis burden, TT prevalence was modelled for sex-specific ten-year age groups using logistic regression. Prevalence of TT was calculated for ten-year age groups for males and females separately for each zone. Ten-year age population structures by sex were obtained for each zone from the Amhara Regional Health Bureau [14] and applied to the ten-year age group TT prevalence estimates for males and females. The 95% confidence intervals of the point prevalence estimates were multiplied by the respective population structure estimates to derive the lower and upper bounds of the TT burden. All zonal estimates and corresponding upper and lower bounds were summed to derive the state-wide estimate of those requiring TT surgery. Ethical consideration The protocol received ethical approval from the Emory University Institutional Review Board (IRB 1816) and the Amhara Regional Health Bureau. Verbal informed consent to participate in interviews and trachoma screening was sought from the heads of the household, each individual and the parents of children aged 10 years and younger in accordance with the tenets of the declaration of Helsinki. Signed informed consent was sought from each individual and parents of children aged 10 years and younger in accordance with the tenets of the declaration of Helsinki for blood films. Personal identifiers were removed from the data set before analyses were undertaken. Results Characteristics of study households and participants A total of 4,122 households were selected for the survey of which 21 were excluded since no one was present: 4,101 (99.5%) were included in the analysis (Figure 2). The characteristics of the study households are shown in Table 1, and the location of the sites surveyed are represented on Figure 1. The overall mean household size was 4.6 persons (95% confidence interval [CI] 4.5–4.7) with household size ranging from 1 to 17. The main source of drinking water came from ‘safe’ sources for 34.4% (95% CI 27.8–64.3) of households and the round-trip time to collect water was  = 30 minutes (%) Mosquito nets Insecticide sprayed in the last year (%) Any net % LLIN % Mean number of LLIN per HH Amhara Region 19,391,698 160 4,101 4.6 57.1 75.7 25.9 34.7 16.1 0.3 14.8 Zones North Gondor 3,241,161 16 392 4.7 55.1 85.4 60.3 50.5 33.4 0.5 9.8 Waghemira 375,440 16 410 5.0 91.7 94.3 53.1 52.8 52.0 0.8 8.4 South Gondor 2,243,477 16 415 5.0 74.0 76.6 3.6 55.6 4.1 0.1 13.6 North Wollo 1,636,699 16 404 4.5 79.1 49.8 12.8 47.2 30.1 0.4 16.6 West Gojjam 2,674,974 16 400 4.5 15.8 82.8 39.0 33.8 13.7 0.2 24.5 Awi 1,090,879 16 395 5.0 46.7 54.1 25.7 21.3 9.4 0.1 13.7 East Gojjam 2,470,060 16 459 4.2 21.7 81.6 26.7 5.6 0 0 8.8 South Wollo 2,878,970 16 403 4.1 81.5 74.2 10.8 6.1 4.0 0.04 2.5 Oromiya 588,943 16 400 5.8 76.9 59.4 36.1 99.9 53.6 1.2 57.4 North Shewa 2,191,096 16 423 5.2 62.4 91.1 21.4 19.2 11.2 0.2 9.3 * Bureau of Finance and Economic Development for the year 2006/2007 HH, household; LLIN, Long lasting insecticidal net Table 2 shows the individual characteristics of study participants and mosquito net usage. A total of 19,710 people were enumerated of whom 41 were excluded from analysis due to missing data on age or sex. Of the 19,669 people included in the sample, the overall mean age was 21.9 years (95% CI 21.5–22.3) and 48.7% were male. The overall proportion of people reporting sleeping under any mosquito net the previous night was 25.8% (95% CI 21.2–30.9). Among the population with particular vulnerability to malaria, the under five year-olds and pregnant women, sleeping under a mosquito net was reported for 29.2% (95% CI 24.1–34.9) and 33.6% (95% CI 25.4–42.8), respectively. Persons reporting sleeping under an LLIN the previous night were: 12.5% (95% CI 9.4–16.5) overall. Of the vulnerable groups, 425/2,929 children aged less than 5 years, 14.5% (95% CI 10.8–19.2); and 46/315 pregnant women, 14.6% (95% CI 10.0–21.0) reported sleeping under an LLIN last night. 10.1371/journal.pntd.0000197.t002 Table 2 Characteristics of study participants and net usage Participants characteristics Proportion of people reporting sleeping under a net last night (%) Domain Number included in the sample Mean Age Male (%) Unclean face in children (%)** Slept under any net Slept under LLIN All people Under fives Pregnant women All people Under fives Pregnant women Amhara Region 19,669 21.9 48.7 25.9 25.8 29.2 33.6 12.5 14.5 14.6 Zones North Gondor 1,892 20.5 47.8 18.6 34.3 38.7 62.4 23.0 27.4 38.1 Waghemira 2,018 21.7 51.2 53.6 38.7 45.5 78.8 37.6 43.9 77.3 South Gondor 2,094 21.0 52.3 24.1 37.3 39.0 59.5 1.7 2.4 2.0 North Wollo 1,812 23.3 48.5 32.9 31.0 31.8 0.0 21.6 20.6 0.0 West Gojjam 1,812 21.2 47.7 25.3 21.3 24.3 27.3 8.5 10.4 18.5 Awi 1,965 20.2 48.6 74.9 15.5 18.1 10.6 7.4 7.2 4.1 East Gojjam 1,949 22.2 45.6 42.8 2.1 4.0 6.4 0.0 0.0 0.0 South Wollo 1,653 23.6 48.1 3.2 4.5 4.1 14.7 2.9 2.1 4.8 Oromiya 2,289 20.7 48.9 22.2 91.7 97.1 96.5 48.3 51.1 43.6 North Shewa 2,185 23.0 48.9 23.7 14.3 14.8 12.6 8.7 8.6 3.5 LLIN, Long lasting insecticidal net Figure 2 shows the sample population and those recruited for trachoma examination and malaria parasite prevalence. Trachoma examination was conducted in 17,242 (87.7%). A total of 9,140 people in even numbered households were eligible for malaria testing of whom 7,745 were included in the analysis (84.7%). Malaria prevalence The malaria parasite prevalence by blood slide microscopy is shown on Table 3. A total of 7,745 blood slides were examined with good concordance between first and second reading. The overall malaria parasite prevalence in Amhara was 4.6% (95% CI 3.8–5.6) with prevalence by zone ranging from 2.4% (95% CI 1.5–4.0) in Oromiya to 6.1% (95% CI 4.5–8.5) in South Gondor. There were no differences in the proportion of people with positive blood slides by age group: age 50 years, 4.2%. The malaria species seen most frequently was P. falciparum, 52.2% of positive slides had P. falciparum only and 8.7% were mixed P. falciparum and P. vivax. Plasmodium vivax only was seen on 41.3% of the positive slides. The overall ratio of P. falciparum to P. vivax was 1.2 with zonal estimates ranging from 0.9 to 2.1. 10.1371/journal.pntd.0000197.t003 Table 3 Prevalence of malaria by blood slide microscopy Domain Number examined Malaria parasite prevalence (%) Pf:Pv ratio P.falciparum only P.vivax only Mixed Pf and Pv Total* % (95% CI) Amhara Region 7,745 2.4 1.9 0.4 4.6 (3.8–5.6) 1.2 Zones North Gondor 703 3.1 2.8 0.0 5.9 (4.2–8.2) 1.1 Waghemira 809 2.0 1.0 0.2 3.1 (1.5–6.4) 1.9 South Gondor 744 2.7 2.5 0.8 6.1 (4.3–8.5) 1.1 North Wollo 835 1.3 1.5 0.4 3.1 (1.5–6.2) 0.9 West Gojjam 713 1.5 1.7 0.3 3.4 (1.7–6.7) 0.9 Awi 799 2.4 2.8 0.4 5.6 (2.4–12.3) 0.9 East Gojjam 699 2.9 1.6 0.4 4.9 (2.4–9.6) 1.7 South Wollo 758 3.6 1.5 0.5 5.6 (3.2–9.4) 2.1 Oromiya 825 1.0 1.1 0.3 2.4 (1.5–4.0) 0.9 North Shewa 860 2.6 2.0 0.2 4.8 (2.7–8.4) 1.3 CI, confidence interval; Pf, Plasmodium falciparum; Pv, Plasmodium vivax * Total parasite prevalence do not equal the sum of the species prevalence in some rows due to rounding Trachoma prevalence The key trachoma prevalence indicators are shown in Table 4. The overall prevalence of TF in children aged 1–9 years was 32.7% (95% CI 29.2–36.5). Prevalence of TF in children by zone ranged from 12.6% (95% CI 7.8–19.7) in South Wollo to 60.1% (95% CI 50.4–69.0) in Waghemira. There was no sex difference in TF prevalence: Odds Ratio (OR) = 1.0 (95% CI 0.9–1.2). The overall prevalence of TT in persons aged 15 years and above was 6.2% (95% CI 5.3–7.4). Point estimates by zone of TT prevalence in adults ranged from 2.4% (95% CI 1.4–4.1) in Oromiya to 10.0% (95% CI 6.3–15.6)in West Gojjam. After adjusting for age, adult women were three times more likely to have TT than men: OR = 3.1; (95% CI 2.3–4.1). Trichiasis was also observed in children aged less than 15 years with an overall prevalence of 0.3% (95% CI 0.2–0.5) in the age group 0–14 years, ranging from 0% in North Gondor to 0.8% (95% CI 0.3–1.8) in North Wollo. 10.1371/journal.pntd.0000197.t004 Table 4 Key trachoma prevalence indicators: trachomatous inflammation–follicular (TF) and trachomatous trichiasis (TT) Domain TF in children aged 1–9 years TT in children aged 0–14 years TT in people aged 15 and above Number examined Prevalence Number examined Prevalence Number examined Prevalence % 95% CI % 95% CI % 95% CI Amhara Region 5,485 32.7 29.2–36.5 8,121 0.3 0.2–0.5 9,121 6.2 5.3–7.4 Zones North Gondor 466 34.7 24.4–46.8 700 0 730 4.3 2.8–6.6 Waghemira 581 60.1 50.4–69.0 918 0.5 0.2–1.5 1,030 6.3 3.9–9.9 South Gondor 589 28.9 20.1–39.6 887 0.1 0.01–0.4 904 3.8 2.5–5.7 North Wollo 539 51.9 35.4–68.0 739 0.8 0.3–1.8 971 9.4 7.2–12.1 West Gojjam 500 33.1 25.3–42.0 774 0.4 0.1–1.3 874 10.0 6.3–15.6 Awi 588 38.9 22.7–57.9 866 0.1 0.01–0.4 893 5.4 4.0–7.3 East Gojjam 548 48.3 44.4–52.2 798 0.3 0.1–0.8 881 7.1 5.4–9.4 South Wollo 484 12.6 7.8–19.7 701 0.3 0.1–1.4 931 3.2 2.2–4.6 Oromiya 663 28.7 19.6–39.8 958 0.1 0.02–0.8 964 2.4 1.4–4.1 North Shewa 527 23.2 14.1–35.9 780 0.3 0.1–1.1 943 9.0 6.7–11.9 CI, confidence interval Trichiasis burden estimates Estimates of trichiasis burden are summarized in Table 5. The number of people with TT in Amhara was estimated to be 643,904 (lower and upper bounds = 419,274–975,635). Consistent with the increased odds of TT in women, the TT burden in females (of all ages) was estimated to be 2.2 fold compared to males. For planning purposes, the number of persons requiring corrective trichiasis surgery in Amhara was estimated to be 645,000. 10.1371/journal.pntd.0000197.t005 Table 5 Trichiasis burden estimates by gender Domain Male Female Total Point estimate Lower bound Upper bound Point estimate Lower bound Upper bound Point estimate Lower bound Upper bound Amhara Region 199,929 122,889 321,230 443,975 296,386 654,405 643,904 419,274 975,635 Zones North Gondor 21,996 13,378 35,843 49,669 31,605 76,663 71,665 44,984 112,506 Waghemira 4,716 2,807 7,773 10,127 6,391 15,581 14,844 9,198 23,354 South Gondor 15,579 9,285 25,908 35,344 22,278 55,051 50,923 31,563 80,960 North Wollo 29,631 19,314 44,762 63,163 45,666 86,186 92,795 64,980 130,948 West Gojjam 42,729 23,540 74,338 88,644 56,656 133,936 131,373 80,196 208,273 Awi 9,531 6,337 14,274 21,699 15,286 30,557 31,230 21,622 44,832 East Gojjam 24,751 16,195 37,634 56,644 39,415 80,682 81,395 55,610 118,316 South Wollo 17,353 10,214 29,286 44,541 28,447 68,778 61,893 38,662 98,064 Oromiya 2,193 1,214 3,930 5,694 3,298 9,640 7,886 4,512 13,570 North Shewa 31,449 20,605 47,483 68,451 47,342 97,331 99,900 67,947 144,813 Lower and upper bounds represents the 95% confidence interval of the point estimates Discussion This integrated survey of malaria and trachoma demonstrates that malaria is endemic in all zones of Amhara, an area of unstable malaria transmission, and that malaria parasites can be demonstrated at the end of the transmission season in a non-epidemic year. The key malaria indicators of mosquito net coverage and proportion of different population groups sleeping under long-lasting insecticidal nets (LLINs) demonstrated in the survey will be used as a baseline for planning and evaluation of the regional malaria control program. The survey has underscored the public health significance of blinding trachoma and allowed the calculation of intervention targets per zone with unprecedented precision. Conducting an integrated survey has maximized the benefits of organizing a complex survey without significant increases in the time required in the field or the effort of the field teams. Selecting the sample and conducting field work posed considerable logistical challenges. The mountainous nature of Amhara makes transportation particularly difficult and field teams were obliged to walk for up to eight hours in order to reach some of the selected clusters. In accordance with the state definition of “malarious”, three urban centers (comprising 0.4% of the total population) were excluded from the sampling frame. By integrating malaria and trachoma, prevalence estimates, indicators, and risk factors for both diseases could be obtained for the cost of conducting one disease survey with an incremental addition of one person per field team. If the base survey were for malaria, the field team would require a trained trachoma examiner, if the base survey were for trachoma, the field team would require a clinical technician to take the blood slides. All interviewing, record-keeping, and form-checking would be constant. In order to achieve the required sample size for the estimation of trichiasis, we required twice the number of people needed to estimate malaria parasite prevalence. We arbitrarily selected even-numbered households for malaria parasite prevalence and all households for trachoma. Since there were twenty-five households sampled and numbered sequentially per cluster, this resulted in systematically sampling 12 households for malaria parasite prevalence per cluster, or slightly less than half, and not half of all households. Such inadvertent compromises are likely to occur in integrated surveys and extremely careful planning is required to ensure that the overall objectives required to measure two or more outcomes are achieved. This integrated survey required considerably more pre-planning and coordination than a single disease survey, yet a relatively minor increase in implementation effort. The overall benefits of integration far outweighed the total effort required to plan, conduct and finance two separate surveys. Amhara is prone to unstable epidemic malaria and the survey was conducted at the end of the transmission season in a non-epidemic year. The data presented here provide the first comprehensive representative baseline data of malaria parasite prevalence, species ratios and malaria indicators for the region. The parasite prevalence is consistent with that reported for unstable transmission areas in Ethiopia by Newman et al [21]. The Ethiopian Demographic and Household Survey conducted in 2005 estimated the proportion of households in Amhara that had any mosquito net to be 3.8% and the average number of LLINs per household to be 0.0 [22]. Our data suggest that by the end of 2006 considerable progress has been made in the Amhara Regional State malaria control program, as these indicators have risen to 34.7% of households with any net and a mean of 0.3 LLINs per household. In addition, these data show what needs to be accomplished if the national target of having everybody at risk of malaria sleeping under an insecticidal net, with a mean of two LLINs per household by the end of 2007 are to be achieved. We included the use of rapid diagnostic tests (RDT) in the field component of the survey in order to maximize the likelihood that participants who were parasite positive received prompt and effective treatment. After the blood slides were read, it was possible to link back to the database and determine the proportion of participants positive by microscopy who were also positive by RDT. There was not absolute concordance between microscopy, which is considered the gold standard, and the RDTs. Participants with negative RDTs and positive blood slides were followed up back to the field and provided treatment according to national guidelines. The discordance will be presented in a separate paper. Data collected in the survey are all indicative of the prevalence of the diseases and extent of indicators and risk factors. The prevalence of malaria is time-dependent and will vary from month to month and year to year. There is no known seasonality in presentation of clinical signs of trachoma in Ethiopia; however, the application of the simplified grading system is subjective. Clinical examiners went through a two-stage training and were required to have greater than 80% concordance with the gold standard before joining the field teams, which minimizes but does not exclude the risk of observer bias. It has been argued that nucleic acid amplification techniques of conjunctival swabs are the best way of determining the prevalence of ocular chlamydial infection, although this is currently advocated by the WHO for programmatic use [23]. The 2005/2006 National Survey on Blindness, Low Vision and Trachoma in Ethiopia had a total of 174 clusters of which 33 were in Amhara [2]. The sampling framework was based on probability proportional to size. A total of 4,609 individuals were surveyed but trichiasis was only reported for the adult population (persons aged 15 years and above) who comprise around 50% of the total population. The national survey estimated the TT prevalence in adults in Amhara to be 5.2%. Our survey included 160 clusters and a total of 17,242 persons surveyed for trichiasis. By having 10 domains and 16 clusters in each domain, rather than one domain and 33 clusters used in the national survey, we are able to estimate the trichiasis burden with greater precision, and have the possibility of focusing interventions to the zones of greatest need. Planning for interventions to operate the TT surgical backlog is conducted at the level of the zone. The estimates derived in this survey enable realistic preparation and planning. The threshold for district-wide intervention with mass antibiotic administration, hygiene promotion and environmental change is 10% TF in children aged 1–9 years [19]. The national survey estimated TF in children aged 1–9 years to be 39.1% in Amhara. Our survey found an overall weighted prevalence of 32.7%, ranging from 12.6% to 60.1% by zone, but more importantly for program planning, the threshold of 10% was exceeded in all ten zones. The next steps in terms of integrating the delivery of the control program is to determine where integration makes sense in terms of logistics and to continue with separate activities where there are no potential synergistic gains from integration. For the distribution of LLINs, the FMOH policy of providing two free nets per household is not suitable for integration with the strategy for delivering azithromycin for trachoma control, since only one person per household needs to present themselves for nets whereas the entire household need to present themselves and be measured for mass drug administration. Specific training for health extension workers and village volunteers makes sense logistically and can be integrated. The program will use the findings from the malaria indicator questionnaire and trachoma risk factor questionnaire to design combined health education materials that include promotion of positive existing behaviours that will control malaria and trachoma. The purpose of this paper is to present selected malaria indicators, malaria parasite prevalence, and key trachoma indicators to facilitate planning and evaluation of the Amhara Regional Health Bureau's integrated malaria and trachoma control program. Further analysis is underway to characterise the risk factors and identify the best opportunities for promotion of the integrated control program.
                Bookmark

                Author and article information

                Journal
                21408130
                3050919
                10.1371/journal.pntd.0000979
                http://creativecommons.org/so-override

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article